Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Harvard Bioscience (DE:HBI)
FRANKFURT:HBI
Harvard Bioscience (HBI) Stock Price & Analysis
0 Followers
HBI Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€3.26 - €5.65
Previous Close€3.26
Volume0.00
Average Volume (3M)N/A
Market Cap
€146.79M
Enterprise Value€187.77M
Total Cash (Recent Filing)$4.32M
Total Debt (Recent Filing)$48.20M
Price to Earnings (P/E)N/A
Beta0.54
Next Earnings
May 07, 2024EPS Estimate
€0.03Last Dividend Ex-Date
Nov 04, 2013Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding43,399,291
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)162.13
Price to Sales (P/S)1.25
Price to Cash Flow (P/CF)9.00
P/FCF Ratio9.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.65
Enterprise Value/Gross Profit3.09
Enterprise Value/Ebitda70.72
Forecast
1Y Price Target
€6.30Price Target Upside90.90% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Harvard Bioscience News
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
0.90% Other Institutional Investors
99.10% Public Companies and
Individual Investors
HBI FAQ
What was Harvard Bioscience’s price range in the past 12 months?
Harvard Bioscience lowest stock price was €3.26 and its highest was €5.65 in the past 12 months.
What is Harvard Bioscience’s market cap?
Currently, no data Available
When is Harvard Bioscience’s upcoming earnings report date?
Harvard Bioscience’s upcoming earnings report date is May 07, 2024 which is in 6 days.
How were Harvard Bioscience’s earnings last quarter?
Harvard Bioscience released its earnings results on Mar 07, 2024. The company reported €0.037 earnings per share for the quarter, missing the consensus estimate of €0.047 by -€0.009.
Is Harvard Bioscience overvalued?
According to Wall Street analysts Harvard Bioscience’s price is currently Undervalued.
Does Harvard Bioscience pay dividends?
Harvard Bioscience pays a Notavailable dividend of €1.26 which represents an annual dividend yield of N/A. See more information on Harvard Bioscience dividends here
What is Harvard Bioscience’s EPS estimate?
Harvard Bioscience’s EPS estimate is €0.03.
How many shares outstanding does Harvard Bioscience have?
Currently, no data Available
What happened to Harvard Bioscience’s price movement after its last earnings report?
Harvard Bioscience reported an EPS of €0.037 in its last earnings report, missing expectations of €0.047. Following the earnings report the stock price went down -2.646%.
Which hedge fund is a major shareholder of Harvard Bioscience?
Among the largest hedge funds holding Harvard Bioscience’s share is Harvey Partners LLC. It holds Harvard Bioscience’s shares valued at 14M.
---
Harvard Bioscience Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€6.30 (90.90% Upside)
€6.30 (90.90% Upside)
Blogger Sentiment
Bullish
DE:HBI Sentiment 100%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.24%
12-Months-Change
Fundamentals
Return on Equity
-4.70%
Trailing 12-Months
Asset Growth
-5.50%
Trailing 12-Months
Company Description
Harvard Bioscience
Harvard Bioscience, Inc. develops, manufactures, and markets broad range of specialized products, primarily apparatus and scientific instruments. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.
---
HBI Company Deck
---
HBI Earnings Call
Q4 2024
0:00 / 0:00
---
HBI Stock 12 Months Forecast
Average Price Target
€6.30
▲(90.90% Upside)
Technical Analysis
Harvard Bioscience
―
Bio-Rad Laboratories
―
Thermo Fisher
―
Haemonetics
―
Bio-Techne
―
Best Analysts Covering HBI
1 Year
1 Year Success Rate
5/8 ratings generated profit
1 Year Average Return
+13.11%
reiterated a buy rating 10 months ago
Copying Bruce Jackson's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +13.11% per trade.
---